e-learning
resources
Milan 2017
Monday, 11.09.2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections
Oral Presentation
Chairs:
J. Chalmers (Dundee, United Kingdom), E. Polverino (Barcelona, Spain)
Download all media
Late Breaking Abstract - The prevalence and burden of Pseudomonas aeruginosa among bronchiectasis patients in Europe- data from the FRIENDS cohort
J. Chalmers (Dundee, United Kingdom)
The association between gastro-oesophageal reflux and exacerbations of bronchiectasis: data from the EMBARC registry
M. Mcdonnell (Galway, Ireland)
Sputum Pregnancy Zone Protein (PZP) - a potential biomarker of bronchiectasis severity
A. Smith (Dundee, United Kingdom)
Reduction of the cost associated with exacerbations after treatment with nebulized sodium colistimethate (Promixin®) in patients with bronchiectasis (BQ) and chronic bronchial infection (CBI) with Pseudomonas aeruginosa (PsA).
E. Garcia Cortacero (Granada, Spain)
Eradication treatment in Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) on patients with pseudomonas aeruginosa
M. Kaponi (ATHENS, Greece)
The Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease in Japan
H. Namkoong (Tokyo, Japan)
Changing epidemiology of pulmonary nontuberculous mycobacteria infections over a 20-year period in Biscay, Spain
S. Pedrero Tejada (Santurtzi (Vizcaya), Spain)
Cardiovascular disease risk in patients with nontuberculous mycobacteria disease treated with macrolide
J. Kang (Seoul, Republic of Korea)
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept